Get started
Author

Adrien Labriet

Identification of Yeast and Human 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) Transporters
2014 · Johanna Ceschin, Christelle Saint-Marc, et al. · Journal of Biological Chemistry · 29
PDF
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients
2019 · Adrien Labriet, Éric Lévesque, et al. · Scientific Reports · 25
PDF
UGT2B17 modifies drug response in chronic lymphocytic leukaemia
2020 · Eric P. Allain, Michèle Rouleau, et al. · British Journal of Cancer · 24
PDF
Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression
2020 · Eric Lévesque, Adrien Labriet, et al. · British Journal of Cancer · 20
PDF
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
2018 · Elena De Mattia, Erika Cecchin, et al. · Frontiers in Pharmacology · 19
PDF
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI
2019 · Elena De Mattia, Jerry Polesel, et al. · Frontiers in Oncology · 16
PDF
Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody
2019 · Jean-Philippe Émond, Adrien Labriet, et al. · Drug Metabolism and Disposition · 16
PDF
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L
2017 · Adrien Labriet, Elena De Mattia, et al. · Frontiers in Pharmacology · 13
PDF
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm
2021 · Elena De Mattia, Jerry Polesel, et al. · Cancers · 12
PDF
Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing
2018 · Adrien Labriet, Eric P. Allain, et al. · Drug Metabolism and Disposition · 12
PDF
Combination of Germline Variations Associated with Survival of Folinic Acid, Fluorouracil and Irinotecan-Treated Metastatic Colorectal Cancer Patients
2019 · Adrien Labriet, Éric Lévesque, et al. · Pharmacogenomics · 9
PDF
Abstract 3889: RPL28 promoter polymorphism rs4806668 is associated with reduced survival in FOLFIRI-treated metastatic colorectal cancer patients
2018 · Adrien Labriet, Éric Lévesque, et al. · Cancer Research · 1
Optimiser la pharmacothérapie par la pharmacogénétique – Où en sommes-nous ?
2020 · Adrien Labriet, Isabelle Laverdière · Pharmactuel
PDF
RPL28 Promoter polymorphism RS4806668 is associated with reduced survival in folfiri-treated metastatic colorectal cancer patients
2019 · Adrien Labriet, Eric Levesque, et al. · Drug Metabolism and Pharmacokinetics
Improved progression-free survival in metastatic colorectal cancer patients carriers of the HNF1A coding variant P.I27L treated with irinotecan
2018 · Adrien Labriet, Elena Demattia, et al. · Drug Metabolism and Pharmacokinetics
Identification or yeast and human 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside (AICAr) transporters.
2014 · Ceschin, Johanna, St-Marc, Christelle, et al. · HAL
Works count: 17
Citation count: 196
H-index: 10
I10-index: 10
Year
Topic
Type